Mynzepli

Afliberceptum — sol inj 2 mg/0.05 ml ser pré

Advanz Pharma Specialty Medicine Switzerland GmbH

Swissmedic70617
Dossier22155
Remboursement
QP 10%KG
Modifications (3)